Evofem Biosciences (EVFM) Short Interest Ratio & Short Volume

Short interest is the volume of Evofem Biosciences shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 8,680,000 shares of EVFM short. 22.89% of Evofem Biosciences' shares are currently sold short. Learn More on Evofem Biosciences' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.89% of Evofem Biosciences' floating shares are currently sold short.

Evofem Biosciences saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 8,680,000 shares, a decline of 21.0% from the previous total of 10,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Evofem Biosciences currently has issued a total of 113,356,000 shares. Some of Evofem Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Evofem Biosciences currently has a public float of 37,920,000 shares.

22.89% of Evofem Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Evofem Biosciences: Sunshine Biopharma, Inc. (3.78%), RedHill Biopharma Ltd. (2.09%), Mustang Bio, Inc. (3.10%), InMed Pharmaceuticals Inc. (6.12%), Conduit Pharmaceuticals Inc. (222.54%), Virax Biolabs Group Limited (6.39%), Kazia Therapeutics Limited (0.27%), Galecto, Inc. (5.05%), Purple Biotech Ltd (1.87%), Titan Pharmaceuticals, Inc. (1.11%),

As of the most recent reporting period, the following stocks had the largest short interest positions: KLA Co. ($2.87 billion), Lucid Group, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.08 billion), Coinbase Global, Inc. ($1.91 billion), Williams-Sonoma, Inc. ($1.85 billion), Chesapeake Energy Co. ($1.81 billion), Rivian Automotive, Inc. ($1.64 billion), Lumen Technologies, Inc. ($1.61 billion), Plug Power Inc. ($1.50 billion), and Generac Holdings Inc. ($1.49 billion). View all of the most shorted stocks.

Short selling EVFM is an investing strategy that aims to generate trading profit from Evofem Biosciences as its price is falling. EVFM shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Evofem Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVFM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVFM, twice per month. The most recent reporting period available is July, 31 2022.